Meng-Ning Wei

945 total citations
23 papers, 770 citations indexed

About

Meng-Ning Wei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Meng-Ning Wei has authored 23 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Meng-Ning Wei's work include Drug Transport and Resistance Mechanisms (4 papers), MicroRNA in disease regulation (4 papers) and Cancer therapeutics and mechanisms (3 papers). Meng-Ning Wei is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), MicroRNA in disease regulation (4 papers) and Cancer therapeutics and mechanisms (3 papers). Meng-Ning Wei collaborates with scholars based in China, United States and Macao. Meng-Ning Wei's co-authors include Zhi Shi, Qiwei Jiang, Zihao Xing, Jia-Rong Huang, Di-Wei Zheng, Wenji Zhang, Wu-Ming Qin, Xiao-Long Mei, Youqiu Xue and Yao Li and has published in prestigious journals such as Scientific Reports, Cancer Letters and Signal Transduction and Targeted Therapy.

In The Last Decade

Meng-Ning Wei

23 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meng-Ning Wei China	16	512	233	215	149	66	23	770
Shuling Huang China	16	444 0.9×	278 1.2×	164 0.8×	147 1.0×	28 0.4×	25	854
Chengjian Shi China	15	534 1.0×	523 2.2×	294 1.4×	194 1.3×	65 1.0×	26	1.1k
Nengming Lin China	19	569 1.1×	221 0.9×	173 0.8×	180 1.2×	20 0.3×	55	870
Hyunho Yoon South Korea	16	569 1.1×	365 1.6×	277 1.3×	111 0.7×	29 0.4×	30	1.1k
Minhe Shen China	15	300 0.6×	309 1.3×	186 0.9×	130 0.9×	35 0.5×	36	736
Sima Orouei Iran	16	571 1.1×	167 0.7×	379 1.8×	89 0.6×	27 0.4×	19	848
Yongqian Shu China	18	470 0.9×	403 1.7×	210 1.0×	274 1.8×	91 1.4×	42	1.1k
Shuang Lin China	15	442 0.9×	163 0.7×	255 1.2×	115 0.8×	21 0.3×	34	778
Fanhua Kong China	16	445 0.9×	130 0.6×	255 1.2×	119 0.8×	22 0.3×	40	786
Wenbin Song China	19	540 1.1×	245 1.1×	213 1.0×	204 1.4×	18 0.3×	36	985

Countries citing papers authored by Meng-Ning Wei

Since Specialization

Citations

This map shows the geographic impact of Meng-Ning Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Ning Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Ning Wei more than expected).

Fields of papers citing papers by Meng-Ning Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-Ning Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Ning Wei. The network helps show where Meng-Ning Wei may publish in the future.

Co-authorship network of co-authors of Meng-Ning Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Meng-Ning Wei. A scholar is included among the top collaborators of Meng-Ning Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng-Ning Wei. Meng-Ning Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Di-Wei, Weihai Liu, Wenlin Xie, et al.. (2021). AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma. Signal Transduction and Targeted Therapy. 6(1). 25–25. 33 indexed citations

Liu, Hui, Pei Li, Haifeng Wang, et al.. (2020). miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78. Frontiers in Oncology. 10. 60–60. 33 indexed citations

Huang, Jia-Rong, et al.. (2020). Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer. Frontiers in Pharmacology. 11. 586885–586885. 17 indexed citations

Li, Yao, et al.. (2020). A HPLC-UV Method for the Quantification of Regorafenib in Tumor. 9(1). 1–5. 1 indexed citations

Wei, Meng-Ning, et al.. (2019). Thermal Decomposition and Nonisothermal Kinetics of Monoethanolamine Mixed with Various Metal Ions. Scientific Reports. 9(1). 1592–1592. 13 indexed citations

Xu, Lina, Na Zhao, Jinyan Chen, et al.. (2019). Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo. Frontiers in Oncology. 9. 2–2. 44 indexed citations

Chen, Xu, Haihong Zhou, Yang Yang, et al.. (2019). Survivin Promotes Piperlongumine Resistance in Ovarian Cancer. Frontiers in Oncology. 9. 1345–1345. 15 indexed citations

Wang, Kun, Zihao Xing, Qiwei Jiang, et al.. (2019). Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance. Frontiers in Oncology. 9. 80–80. 28 indexed citations

Zhou, Haihong, Chen Xu, Jiahua Chen, et al.. (2019). Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer. Frontiers in Oncology. 9. 1398–1398. 107 indexed citations

10.

Li, Pei, Yang Yang, Ankui Yang, et al.. (2019). Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma. Cell Death and Disease. 10(12). 916–916. 25 indexed citations

11.

Li, Pei, Zihao Xing, Jinming Di, et al.. (2018). Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma. Frontiers in Pharmacology. 9. 1041–1041. 21 indexed citations

12.

Y, Jin, Qiwei Jiang, Yang Yang, et al.. (2018). Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8+ T Cells in Non-small Cell Lung Cancer. Frontiers in Oncology. 8. 631–631. 32 indexed citations

13.

Xu, Lina, Yanyan Zhang, Na Zhao, et al.. (2018). YM155 enhances docetaxel efficacy in ovarian cancer.. PubMed. 10(3). 696–708. 12 indexed citations

14.

Huang, Jia-Rong, Wu-Ming Qin, Kun Wang, et al.. (2018). Cyclin-dependent kinase 7 inhibitor THZ2 inhibits the growth of human gastric cancer in vitro and in vivo.. PubMed. 10(11). 3664–3676. 26 indexed citations

15.

Wang, Yi‐Jun, Yunkai Zhang, Guan-Nan Zhang, et al.. (2017). Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study. Cancer Letters. 396. 145–154. 64 indexed citations

16.

Li, Yong, Meng-Ning Wei, Yao Chen, et al.. (2016). Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer. Cancer Letters. 386. 100–109. 31 indexed citations

17.

Qiu, Jian-Ge, Yaojun Zhang, Jinming Zhao, et al.. (2015). Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter. Oncotarget. 6(17). 15494–15509. 61 indexed citations

18.

Jiang, Qiwei, Kejun Cheng, Xiao-Long Mei, et al.. (2015). Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. Oncotarget. 6(32). 32790–32804. 56 indexed citations

19.

Xue, Youqiu, Kejun Cheng, Jian-Ge Qiu, et al.. (2015). Antioxidant and Anticancer Activities of Raspberry Extracts. 4(2). 1 indexed citations

20.

Mei, Xiao-Long, Yang Yang, Yaojun Zhang, et al.. (2015). Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo.. PubMed. 5(11). 3311–24. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact